AM-7209 | m-entrepreneurship.com

Product Name :
AM-7209

Search keywords :
AM-7209

drugId :
null

Target Vo:
p53-binding protein Mdm-2

Target Vo Short Name :
MDM2

Moa_Name:
p53-binding protein Mdm-2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Amgen Inc

Active Company_Name :
Amgen Inc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Chk1 Antibody
FXR1 Antibody
Bcl2 Antibody (YA824): Bcl2 Antibody (YA824) is a non-conjugated and Mouse origined monoclonal antibody about 26 kDa, targeting to Bcl2 (1D8). It can be used for WB assays with tag free, in the background of Human, Rat, Mouse.

Author: Betaine hydrochloride

Related Posts